The influence of gender not only on patterns and levels of drug consumption in Europe but also on how responses to drug problems are planned and implemented is explored in this Selected issue. Based on a scientific analysis of the available data, it concludes that policymakers, professionals and scientists must always take gender into consideration in the planning of research, analysis, interventions and policy in the drugs field.